Novel Molecular Determinants of Insulin Clearance
Date Published March 15, 2026
Investigating molecular determinants of insulin clearance to advance metabolic disease therapies.
"Novel Molecular Determinants of Insulin Clearance is a research aims to understand and address common metabolic diseases—particularly those affecting the Southern California population—this project focuses on elucidating the molecular mechanisms that govern insulin clearance, a key physiological process with important implications for obesity, diabetes, and dyslipidemia. As part of a multidisciplinary effort across the university’s colleges and departments, the study situates insulin clearance within a translational framework that seeks to identify genes and mechanisms underlying metabolic dysfunction and to translate those discoveries into new therapeutic strategies.
The project draws on the Diabetes and Endocrinology group’s emphasis on integrated approaches to metabolic disease. The research objective is to define novel molecular determinants that regulate how insulin is removed from circulation, with the goal of clarifying how alterations in clearance contribute to pathological states such as insulin resistance and dysregulated lipid metabolism. By prioritizing genetic and mechanistic discovery, the work aims to bridge fundamental biology with clinical relevance, informing potential interventions that could modify disease trajectory or complement existing treatments.
The program’s broader interest in connections between systemic metabolic health and oral health, recognizing that diabetes intersects with conditions such as periodontal disease and tooth loss. While its primary focus is molecular and mechanistic, the insulin clearance project is designed with an eye toward integrated care strategies and translational pathways that could ultimately support more holistic management of metabolic disorders.
The project aims to contribute foundational knowledge that could inform novel therapies and integrated care strategies addressing obesity, diabetes, dyslipidemia, and related oral health outcomes within affected communities.
Learn more
COM Affiliation
Funding Type
Federal Government Award
Update This Listing
Help us provide the most up-to-date information about this project.
Contact UsQuestions?
For questions about these research projects please email us.
Contact Us